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Abstract
Vitamin D (VitD) is an endogenous immunomodulator that could protect from HIV-1 infection reducing immune
activation and inducing the expression of anti-HIV-1 peptides. To establish a correlation between VitD and natural
resistance to HIV-1 infection, a case-control study using blood and mucosa samples of 58 HIV-1-exposed but
seronegative (HESN) individuals, 43 HIV-1 seropositives (SPs) and 59 non-exposed healthy controls (HCs) was
carried out. The VitD concentration in plasma was determined by ELISA, and mRNA relative units (RU) of VDR,
IL-10, TGF-β, TNF-α and IL-1β in peripheral blood mononuclear cells (PBMCs), oral and genital mucosa was
quantified by qRT-PCR. mRNA levels of human beta-defensin (HBD) -2 and -3 were previously reported and used for
correlations. Significantly higher levels of VitD were found in plasma as well as higher mRNA RU of VDR in PBMCs,
and in genital mucosa from HESN compared to HCs. In addition, higher mRNA RU of TNF-α, IL-1β and IL-10, and
lower mRNA RU of TGF-β were found in PBMC from HESNs compared to HCs. We also observed higher IL-10
mRNA RU in genital mucosa of HESNs compared to HCs, and the mRNA levels of TNF-α in oral and genital mucosa
of SPs were higher compared to HESNs. Furthermore, positive correlations between VDR and IL-10 mRNA RU in
PBMCs and genital mucosa of HESNs were found. Finally, HBD-2 and HBD-3 mRNA RU were positively correlated
with VDR mRNA expression in oral mucosa from HESNs. These results suggest that high levels of VitD and its
receptor are associated with natural resistance to HIV-1 infection. Up-regulation of the anti-inflammatory IL-10, and
the induction of anti-HIV-1 defensins in mucosa might be part of the mechanisms involved in this association.
However, further studies are required to define causal associations.
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Introduction
Several mechanisms of protection against HIV-1 infection
have been reported in HIV-1 highly exposed, but seronegative
(HESN) individuals (Reviewed in 1); however, they do not
explain the absence of infection in all HESNs. Therefore,
further studies are required to fully understand the
phenomenon of HIV-1 natural resistance to define new
therapeutic targets.
Beyond its role in mineral metabolism, vitamin D (VitD) has
immunomodulatory effects [2,3]. Along with its receptor (VDR),
they induce transcription of antimicrobial peptides [4] such as
human beta defensins (HBD) that possess anti-HIV-1 activity in
vitro [5], and play a potential protective role during exposure to
HIV-1 in oral mucosa of the Colombian HESN population [6],
(Zapata et al., 2012, submitted for publication). Moreover, VitD
might reduce the immune activation and the number of viral
target cells [2,3,7], further supporting its beneficial role in
natural resistance to HIV-1 infection.
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In contrast, other studies have shown that the VitD/VDR
complex enhances activation of the HIV-1 promoter located in
the long terminal repeats [8,9]. Additionally, genetic variants
related to high VitD and VDR function have been associated
with susceptibility to HIV-1 infection [10], suggesting a potential
pathogenic role of the VitD/VDR axis.
These apparently contradictory data underline the
importance of further studies on this topic, and suggest that the
VitD pathway may have a dual role during HIV-1 infection.
Particularly, VitD could be beneficial avoiding HIV-1 infection
during virus exposure or reducing immune activation during the
acute phase, the main pathogenic mechanism associated with
this infection. In contrast, during chronic infection VitD could be
detrimental, impairing the immune response against the virus.
Therefore, to establish an association between VitD and
natural resistance to HIV-1 infection, we compared the levels of
i) plasma VitD; ii) VDR mRNA; iii) mRNA of the cytokines
Interleukin (IL)-10, Transforming Growth Factor beta (TGB-β),
Tumor Necrosis Factor alpha (TNF-α) and IL-1β, and iv) mRNA
of the antimicrobial peptides HBD-2 and HBD-3 in peripheral
blood mononuclear cells (PBMCs) and in mucosa samples of
HESN, HC and SP individuals.
Materials and Methods
Population and samples
This is a cross-sectional study involving a cohort of
Colombian sexual serodiscordant couples composed of 58
HESN and 43 chronically HIV-1-infected subjects, hereafter
called seropositives (SPs); they were recruited from the HIV-1
comprehensive care programs in Santa Marta and Medellín,
Colombia. We also included 59 non-exposed healthy control
(HC) volunteers with similar demographic backgrounds as the
HESN and SP individuals. The inclusion criteria for HESN
subjects were previously reported [6,11]; briefly, the HESNs in
this study had unprotected sexual intercourse with an SP
partner more than five times monthly within at least 2 years of
follow up, a negative HIV-1 ELISA test and no other infectious
diseases at sampling.
HC individuals have a negative HIV-1 ELISA test, fewer than
2 sexual partners in the last 2 years and self-reported no risk
behaviors for HIV-1 infection. A complete demographic profile
is shown in table 1.
Furthermore, to rule out stratification bias we defined the
principal component of ancestry of SPs and HESNs by
determining and comparing the frequency of 17 single
nucleotide polymorphisms used as ancestry informative
markers (delta value ≥ 0.40 [12]) with the reported frequencies
in samples from Africa and Europe (1000 genome catalog:
http://browser.1000genomes.org/index.html).
All individuals signed an informed consent prepared
according the Colombian Legislation and this study was
approved by the Bioethics Committee, Universidad de
Antioquia.
Mucosal samples from oral, vaginal and endocervical
mucosa were taken from all individuals using a cytobrush, as
previously described [6]. Blood from 23 HESNs, 38 HCs and 23
SPs was obtained and plasma was separated by blood
centrifugation at 380 x g for 10 min; peripheral blood
mononuclear cells (PBMCs) were isolated by gradient
centrifugation at 400 x g for 30 min using Ficoll-Hypaque
(Sigma), following the manufacturer’s instructions. In addition,
mRNA relative units (RU) of HBD-2 and HBD-3 sampled from
the mucosa of this serodiscordant cohort in a previous study
(Zapata et al., 2012, submitted for publication), were used to
correlate them with VDR mRNA expression.
Plasma vitamin D and VDR mRNA quantification
Plasma VitD [25(OH)D] levels were quantified by an
electrochemiluminescence immunoassay (Cobas - Roche),
following the manufacturer’s instructions.
Total RNA was extracted from PBMCs and mucosal samples
using TRizol Reagent (Invitrogen, Carlsbad, CA) following the
manufacturer’s instructions. RNA was treated with DNase I and
Ribolock (Thermo Scientific, St. Leon-Rot, Germany) and
stored at -70°C until used as previously reported [6].
cDNA was synthesized using random hexamers and the
Revertaid H Minus Retrotranscriptase (Thermo Scientific)
following the manufacturer’s instructions.
Quantitative real time PCR (qPCR) was performed using 15
µL final volume of 2 µL cDNA, 1X Maxima probe qPCR master
mix kit (Thermo Scientific) and 0.35X of hydrolysis probes
(TaqMan®, from Applied Biosystems), for VDR
(Hs01045844_m1), and the reference genes β-actin
(4310881E) and phosphoglycerate kinase 1 (PGK1)
(Hs00943178_g1).
In addition, 1X Maxima SYBR green qPCR master mix kit
(Thermo Scientific) and 260 µM of specific primers for IL-10
(Fw: 5’-GCTGAGAACCAAGACCCAGAC-3’ and Rv: 5’-
GGAAGAAATCGATGACAGCG-3’), TGF-β (Fw: 5’-
CAGCAACAATTCCTGGCGATA-3’ and Rv: 5’-
AAGGCGAAAGCCCTCAATTT-3’), TNF-α (Fw: 5'-
Table 1. Demographic profile.
Characteristics
HESN
(n=58) HC (n=59) SP (n=43)
Age, mean years ± SD 34.9 ±10.3 32.8 ± 9.8 33.7 ± 7.1
Males, n (%) 24 (41.4) 25 (42.4) 23 (53.5)
VL. median (interquartile
range) … … 2,569 (400 - 25,250)
CD4+ T cell/µL count. median
(interquartile range) ND ND 357 (186 - 464)
HAART-naïve, [n, %] [VL
median (interquartile range)] … …
[15, 35] [10,257 (718 -
23,188)]
HAART-responders, [n, %] [VL
maximum] … … [10, 23.3] [<400]
HAART-non-responders [n, %]
[VL median (interquartile
range)]
… … [18, 41.9] [35,806(18,200 – 118,770)]
HESN: HIV-1 exposed seronegative; HC: Healthy controls; SP: Seropositives, SD:
Standard deviation; VL: Viral Load (copies/mL); ND: Not determined.
doi: 10.1371/journal.pone.0082717.t001
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CCCATGTTGTAGCAAACCCTC-3' and Rv: 5'-
TATCTCTCAGCTCCACGCCA-3'), IL-1β (Fw: 5'-
CTCGCCAGTGAAATGATGGCT-3' and Rv: 5'-
GTCGGAGATTCGTAGCTGGAT-3') and the reference genes
β-actin (Fw: 5'-CTTTGCCGATCCGCCGC-3' and Rv: 5'-
ATCACGCCCTGGTGCCTGG-3') and PGK1 (Fw: 5'-
GTTGACCGAATCACCGACC-3' and Rv: 5'-
TCGACTCTCATAACGACCCGC-3') were used. The cycling
profiles in all experiments were: 95°C for 10 min, followed by
40 cycles at 94°C for 15 sec, and annealing/extension for 1 min
at 60°C. Relative expression units of mRNA (RU) was
calculated by the ΔCt method [13], using the expression of β-
actin and PGK1 to normalize the amount of RNA in the
samples. The Bio-Rad CFX manager 3.0 (Bio-Rad) was used
to acquire the cycles thresholds that were determined in each
sample using a regression fit in the linear phase of the PCR
amplification curve. Triplicate assays were performed (SD were
less than 0.3 cycles in all assays). The results are given as
median of relative expression units to two reference genes.
Statistical analysis
The categorical variables in different groups of individuals
were compared using the chi-square test. According to
bivariate normality assumption through the Shapiro–Wilk test, a
two-tailed parametric t-test was used to compare the levels of
25(OH)D, and a non-parametric test (Mann-Whitney U-two-
tailed test) to compare the relative units of the mRNAs of VDR,
IL-10, TGF-β, TNF-α and IL-1β between HESN and both, SP
and HC individuals. A two-tailed p value <0.05 was considered
statistically significant; furthermore, we used a Bonferroni test
for adjusting by the number of comparisons. The correlations
between VDR mRNA and viral load, 25(OH)D, transcript levels
of IL-10, TGF-β, TNF-α, IL-1β, HBD-2 or HBD-3 were
evaluated using the Spearman coefficient rank (r). The
statistical tests were performed using the GraphPad Prism
version 6.0
Results
Demographic data
We analyzed samples of 58 HESN, 43 SP and 59 HC, and
no significant differences were found regarding demographic
backgrounds among the groups (Table 1). The median viral
load of SP individuals was 2,569 RNA copies/mL (interquartile
range= 400–25,250 copies/mL) and the HESNs showed a
monthly average of 8 unprotected sexual oral/anal/vaginal
intercourse events with their SP partner within 2 years of
enrollment, suggesting a moderate risk of acquiring the virus.
In addition, 47% of SP and 27% of HESN reported a previous
sexually transmitted disease. Finally, although the majority
(80%) of sexual orientation in the serodiscordant cohort was
heterosexual, bisexual orientations was also present (20%). In
addition, a similar ancestry component, and pair-wise fixation
index (FST) values indicated that our discordant couples were
not stratified as previously shown [14].
Higher vitamin D levels and VDR mRNA expression are
associated with resistance to HIV-1 infection
To determine whether plasma 25(OH)D levels and
transcripts of VDR could be associated with natural resistance
to HIV-1 infection, their expression was compared between
HESN and both, SP and HC individuals.
Significantly higher 25(OH)D levels were found in plasma of
HESNs compared to HCs (mean±SD; 40.81±18.40 vs.
26.69±9.64 ng/mL, respectively, p=0.0060; Figure 1a); no
significant differences in 25(OH)D levels were observed
between HESNs and SPs (p=1.0000; Figure 1a).
The VDR mRNA expression in PBMCs, oral, vaginal and
endocervical mucosa was then compared. Significantly higher
VDR mRNA expression occurred in HESNs vs. HCs in PBMCs
(median [interquartile range] 0.108 [0.028 - 0.146] vs. 0.011
[0.009 - 0.014], respectively, p<0.0001, Figure 1b), and in
genital mucosa analyzed together as vaginal and endocervical
mucosa (0.049 [0.030 - 0.075] vs. 0.036 [0.023 - 0.062],
respectively, p=0.0210. Figure 1d). Likewise, higher VDR
mRNA RU were observed in vaginal mucosa of HESNs
compared to HCs (0.051 [0.029 - 0.074] vs. 0.034 [0.020 -
0.055], respectively, unadjusted p=0.0332. Figure 1c), but the
statistical significance was lost after the Bonferroni correction
(p=0.0664, Figure 1c). In addition, HESNs showed significantly
higher VDR mRNA levels compared to SPs in PBMCs (0.108
[0.028 - 0.146] vs. 0.048 [0.019 - 0.069], respectively,
p=0.0092. Figure 1b), but no significant differences between
HESNs and SPs were found in mucosa samples (Figure 1c,
1d). Finally, no significant differences in VDR mRNA
expression levels in oral or endocervical mucosa were detected
between HESN and HC or SP individuals (data not shown). We
also analyzed the data stratified by gender, and no significant
differences were found.
In addition, a positive correlation between plasma levels of
25(OH)D and levels of VDR mRNA in PBMCs was detected
(r=0.56, p=0.0008, Figure 1e).
Finally, since VDR levels as observed in PBMCs and genital
mucosa of HESN and SP individuals could be induced by viral
exposure, correlations between viral load and VDR mRNA
levels in SP individuals was evaluated; however, no significant
correlation was found (r=0.33, p=0.2274).
HESNs exhibit an up-regulation of IL-10 than HCs in
mucosa, maintaining similar levels of TNF-α, IL-1β and
TGF-β
As VitD displays anti-inflammatory properties [2,3,7] with a
potential impact reducing immune activation, the main
pathogenic mechanism in HIV-1 infection, the transcriptional
expression of pro-inflammatory (IL-1β and TNF-α) and anti-
inflammatory (IL-10 and TGF-β) cytokines in PBMCs and
mucosa were evaluated to infer the degree of immune
activation.
Higher levels of IL-10 transcripts in vaginal mucosa of
HESNs compared to HCs (0.013 [0.006 - 0.019] vs. 0.006
[0.002 - 0.011], respectively, p=0.0418. Figure 2a) were
observed, whereas, higher levels of TNF-α were found in SPs
compared to HESNs in vaginal (0.102 [0.036 - 0.173] vs. 0.030
[0.021 - 0.074], respectively, p=0.0156. Figure 2a), genital
Vitamin D and Resistance to HIV-1
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Figure 1.  High Vitamin D levels and VDR mRNA expression in HESN individuals.  The box and whisker plots show
significantly higher levels of 25(OH)D levels in plasma (A), relative mRNA units, RU, of VDR in PBMCs (B), vaginal (C) and genital
mucosa (vaginal and endocervical mucosa, together) (D) of HESNs (blue) compared to HCs (green). Significantly higher levels of
VDR RU in PBMCs of HESNs than in SPs (red) are also shown (B). Plasma levels of 25(OH)D from all populations was positively
correlated with VDR mRNA RU in PBMCs (r=0.56, p=0.0008, n=32) (E). VDR mRNA RU was obtained by normalizing it with β-actin
and phosphoglycerate kinase 1 (PGK1) mRNA expression levels. Box: 25–75 percentile range; whiskers: 10–90 percentile range;
outliers are plotted as black circles; medians are the black lines in the boxes and means plotted as a plus and Bonferroni adjusted
significant p values are displayed in each graph. A two-tailed parametric t test was used to compare the levels of 25(OH)D, and the
non-parametric test (Mann-Whitney U-two-tailed test) to compare VDR mRNA RU between pairs of groups. The correlations were
evaluated using the Spearman coefficient rank (r). *unadjusted p-value=0.0332.
doi: 10.1371/journal.pone.0082717.g001
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(vaginal and endocervical mucosa, together) (0.102 [0.040 -
0.145] vs. 0.031 [0.021 - 0.075], respectively, p=0.0044. Figure
2b) and oral mucosa (0.041 [0.026 - 0.076] vs. 0.025 [0.012 -
0.043], respectively, p=0.0154. Figure 2c). Furthermore, the
expression levels of TNF-α or IL-1β in mucosa between
HESNs and HCs were similar (Figure 2a,b,c).
In contrast, the mRNAs of pro-inflammatory cytokines TNF-α
and IL-1β were higher in PBMCs of HESNs compared to HCs
(TNF-α: 0.161 [0.092 - 0.335] vs. 0.072 [0.049 - 0.140],
respectively, p=0.0220 and IL-1β: 1.287 [0.569 - 3.947] vs.
0.145 [0.073 - 0.565], respectively, p<0.0001. Figure 2d). No
significant differences were observed between HESNs and
SPs (Figure 2d). In addition, TGF-β mRNA levels in PBMCs
were lower in HESNs than in HCs (0.182 [0.087 - 0.312] vs.
0.335 [0.279 - 0.374], respectively, p=0.0002. Figure 2d) but no
significant differences in TGF-β mRNA in PBMCs or mucosa
were detected between HESNs and SPs (Figure 2).
Furthermore, IL-10 mRNA levels were higher in PBMCs of
HESNs compare to HCs (0.010 [0.005 - 0.023] vs. 0.004 [0.003
- 0.005], respectively, p=0.0056. Figure 2d).
Despite all cytokines mRNA levels were correlated with VitD
and VDR mRNA within each cohort, the only significant
correlation found in the HESN cohort was between VDR mRNA
and IL-10 mRNA in PBMCs (r=0.68; p=0.014. Figure 3a) as
well as in genital mucosa (r=0.37; p=0.0304. Figure 3b).
Finally, no major differences in the evaluated cytokines in
neither blood nor mucosa compartments were observed among
HAART naïve and patients on HAART (responders and non-
Figure 2.  Activation status of HESNs is variable comparing mucosa, versus PBMCs.  The box and whisker plots show the
median value and 10-90 percentiles of mRNA RU of anti-inflammatory IL-10, TGB-β and pro-inflammatory cytokines TNF-α and
IL-1β in vaginal mucosa (A), genital mucosa (vaginal and endocervical mucosa, together) (B), oral mucosa (C) and in PBMCs (D) of
HESNs (blue), HCs (green) and SPs (red). A non-parametric test (Mann-Whitney U-two-tailed test) was used to compare mRNA RU
between study groups. Outliers are plotted as black circles and Bonferroni adjusted significant p values are displayed in each graph.
Significantly lower mRNA RU of TNF-α in vaginal, genital and oral mucosa of HESNs than SPs (A-C) and significantly higher mRNA
RU of IL-10 in vaginal mucosa (A) and PBMCs (D) of HESNs than HCs are shown. In contrast, the PBMCs of HESNs showed
higher levels of the proinflammatory cytokines TNF-α and IL-1β (D).
doi: 10.1371/journal.pone.0082717.g002
Vitamin D and Resistance to HIV-1
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responders), suggesting that all SP individuals have similar
level of immune activation regardless viral load.
Figure 3.  VDR mRNA expression is correlated with mRNA of IL-10 and antimicrobial peptides (HBD-2 and HBD-3) in
HESNs.  There was a significant positive correlation between the mRNAs of VDR and the IL-10 in PBMCs (r=0.68; p=0.0137, n=13)
(A), and in the genital mucosa (r=0.37; p=0.0304, n=34) (B) of HESN individuals. There were also significant positive correlations
between the mRNAs of VDR and the antimicrobial peptides HBD-2 (r=0.61, p=0.0006, n=28) (C), and HBD-3 (r=0.62, p=0.0006,
n=27) (D) in oral mucosa of HESN individuals. The correlations were evaluated using the Spearman coefficient ranks (r), which are
displayed in each graph with the best linear fit lines and p values.
doi: 10.1371/journal.pone.0082717.g003
Vitamin D and Resistance to HIV-1
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VDR mRNA expression was correlated with mRNA of
antimicrobial peptides (HBD-2 and HBD-3) in oral
mucosa of HESNs
Previously, we showed that the mRNA of the antimicrobial
peptides HBD-2 and HBD-3 are expressed in greater amounts
in oral mucosa of the same HESN individuals [6], (Zapata et
al., 2012, submitted for publication). Therefore, correlations
between the mRNA levels of VDR and the antimicrobial
peptides HBD-2 and HBD-3 were evaluated. Significant
positive correlations in oral mucosa of HESNs (r=0.61,
p=0.0006 for HBD-2 and VDR; r=0.62, p=0.0006 for HBD-3 and
VDR; Figure 2c,d) and in oral samples of all individuals (HESN,
SP and HC) (r=0.46, p<0.0001 for HBD-2 and VDR; r=0.44,
p<0.0001 for HBD-3 and VDR) were observed. No significant
correlations in genital mucosa were found (data not shown).
Discussion
Defining the immune factors involved in natural protection
against HIV-1 infection in HESN individuals is a key goal for the
development of vaccines or new therapeutic tools.
The VitD/VDR axis has strong immunomodulatory and
antimicrobial effects [2,4] and could play an important role
modulating the risk of HIV-1 infection; however, reports on the
influence of this axis on HIV-1 infection are contradictory.
We analyzed a cohort of Colombian HESNs, one of the best
characterized HESN cohort so far studied in South America,
and significantly higher plasma 25(OH)D levels were detected
compared to HCs (Figure 1a).
Most importantly, we found significantly higher VDR mRNA
expression levels in PBMCs as well as in genital mucosa, the
primary HIV-1 port of entry [15,16], of HESNs compared to
HCs (Figure 1b,d). However, when the analysis was carried out
in endocervical and vaginal mucosa independently, the
statistical differences were not significant for endocervical
mucosa (unadjusted p=0.1589 Figure 1c) or the significance
was lost after the Bonferrini correction for vaginal mucosa
(unadjusted p=0.0332 and adjusted p=0.0664. Figure 1c);
these results are most likely explained by the reduction in the
sample size. The fact that significant differences in mucosa
were less robust than those in PBMC samples might be due to
compartmentalization issues, and differences in cell
subpopulations: immune cells in peripheral blood versus
epithelial cells in mucosa.
Furthermore, a positive correlation between plasma levels of
25(OH)D and levels of VDR mRNA in PBMCs was detected
(Figure 1e), suggesting that high levels of VitD could induce the
expression of VDR as previously reported in in vitro
experiments [2,17].
To the best of our knowledge, this is the first study reporting
an association between VitD and VDR levels in circulating
immune cells as well as in mucosa samples with natural
resistance to HIV-1 infection. While early studies presented
contradictory results related to the in vitro effect of VitD on
HIV-1 infection [18,19], a recent study reported that VitD could
inhibit HIV-1 infection through autophagy induction [20],
highlighting the beneficial role of VitD by a new proposed
mechanism. Whether autophagy is one of the VitD-induced
protective pathways in HESNs is unknown; thus additional
studies exploring this specific point are required. In addition,
diet, skin color and exposure to sun are aspects influencing
25(OH)D levels [21,22]. Therefore, these should be considered
in further studies.
The possibility that the expression of VDR is virus-induced is
unlikely since no significant correlation was found between
VDR mRNA levels and viral load (r=0.33, p=0.2274), therefore,
our results may indicate a genetic predisposition of HESNs to
up-regulate VDR expression upon an immune challenge.
Although, allelic variants in the VDR gene have been
previously reported in HESN individuals [10], the direct
influence of these variants on 25(OH)D or VDR expression in
HESNs has not been explored. Therefore, to clarify these
findings, it is essential to genotype variants in genes of the VitD
pathway and correlate them with 25(OH)D and VDR
expression; such studies are currently undertaken in our
laboratory.
During infections, the production of cytokines and
chemokines is increased, allowing migration and activation of
effector cells. However, to date it is not clear if this
phenomenon can be detrimental by increasing target cells
[23–26] or protective against HIV-1 infection by promoting
vigorous and effective immune responses that could limit viral
infection [27–29]. In this study, higher levels of IL-10 transcripts
in vaginal mucosa of HESNs compared to HCs were observed
(Figure 2a); moreover, while SPs demonstrated a substantially
increased production of TNF-α in both the genital tract and oral
mucosa compared to HESN individuals, the expression levels
of TNF-α and IL-1β in mucosa of HESNs and HCs were similar
(Figure 2a,b,c). These results, suggest that despite viral
exposure, the HESNs, may control the production of pro-
inflammatory cytokines, which is in accordance with previous
studies indicating lower levels of activation in mucosa tissues
of HESNs [23–26]. In contrast, the HESNs expressed a mixed
pattern of pro- and anti-inflammatory cytokines in PBMCs: they
exhibited significantly higher amounts of mRNA of TNF-α, IL-1β
and IL-10 and lower amounts of mRNA of TGF-β compared to
HCs (Figure 2d). The difference in mucosa and blood
compartments may be explained by the fact that the mucosa
usually exhibits a high regulatory environment required to
prevent tissue damage as a result of constant immune
challenges, whereas PBMCs include circulating cell subsets
with various phenotypes and different activation levels raised
from tissues with diverse antigenic microenvironment.
Considering that individuals of the HESN cohort are sexually
exposed to HIV-1, the mucosa became the most important
tissue in this study, where critical events such as
proinflammatory milieu, the number of viral target cells or
preexisting protective factors may determine the result of HIV-1
exposure.
Furthermore, a significant correlation between VDR mRNA
and IL-10 mRNA were detected in PBMCs (Figure 3a) and in
genital mucosa (Figure 3b) of HESNs. The relationship
between high VDR expression and high IL-10 production in
HESNs is not surprising since a VitD response element
(VDRE) in the IL-10 gene promoter has been identified, that
elicits an increase in IL-10 expression after treatment with VitD
Vitamin D and Resistance to HIV-1
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[30]. Likewise, it has been demonstrated that VitD induces
IL-10 expression in monocytes and CD4+ T cells in vitro [2,31],
targeting epidermal and dermal dendritic cells for the induction
of distinct regulatory T cells, including T regulatory cells 1
(TR1) and IL-10 secreting cells [32], and reducing the
inflammation by decreasing pro-inflammatory cytokines such
as IL-1β and TNF-α [33,34]. Moreover, increased IL-10
secreting cells and IL-10 expression is also seen in humans
supplemented with VitD [35,36], suggesting that VitD/VDR
complex in HESNs might up regulate the expression of IL-10,
and eventually reduce immune activation, at least locally.
Since the VitD/VDR complex promotes the expression of
antiviral proteins [4,37–39], we next investigated whether high
expression of VDR is correlated with the expression of the
antimicrobial peptides, HBD-2 and HBD-3, in the mucosa of
HESNs; indeed, a significant positive correlation between
mRNA levels of VDR and HBD-2 and HBD-3 in oral mucosa of
HESNs (Figure 2c,d) was observed; furthermore, significant
positive correlations in oral samples of all individuals were also
found.
Previous reports have shown that treatment with VitD of
several cell types including epithelial cells, induced along with
VDR, a dose-dependent production of catelicidin, HBD-2 and
HBD-3 antimicrobial peptides [4,17,38,40,41]. This response
restricted the growth of pathogens such as Aggregatibacter
actinomycetemcomitans [17] and Staphylococcus aureus [41]
in the mucosa and oral cavity, enhancing the innate immune
defenses without increasing inflammation [17,41]. Moreover,
oral transmission is a potentially important, yet less well
understood route of HIV-1 infection, where HBDs seem to be
involved in the low rate of oral HIV-1 transmission [42,43].
Since no correlation was detected between VDR and HBDs
mRNA in genital samples, the potential protective role of VDR
through the induction of these antiviral peptides is so far limited
to oral mucosa, pointing to the requirement of further studies to
confirm if VDR-induced HBD expression protects from HIV-1
infection in genital mucosa.
Overall these results suggest that VitD and VDR could
influence the resistant phenotype exhibited by this highly HIV-1
sexually exposed but seronegative Colombian cohort; the most
likely VitD-induced mechanisms involved in avoiding the
establishment of HIV-1 infection would be the up-regulation of
the anti-inflammatory IL-10, and/or the induction of the
antimicrobial peptides HBD-2 and HBD-3 with anti-HIV-1
activity. Considering that the cytokine profile in HESNs’ PBMCs
is different from the one in mucosa, a compartmentalization
effect could be taking place. Since the cross-sectional design
of our study limits causal conclusions, these findings need to
be confirmed by in vitro assays.
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